Harrow HROW
NASDAQ HROW
$41.38 -0.26 (-0.62%)
At close: Aug 20, 2026 · 1:47 PM UTC

Harrow (HROW) Gross Margin (2013 - 2026)

Harrow (HROW) posted quarterly Gross Margin of 61.18% for Q1 2026, down 636.0% year-over-year from 11.41% in Q1 2025, and down 22.82% quarter-over-quarter from 79.27% in Q4 2025.

Harrow (HROW) Gross Margin (2013 - 2026) Analysis & Trends

Harrow's Gross Margin history runs 14 years deep, the most recent figure standing at 61.18% for Q1 2026.

  • In Q1 2026, Gross Margin fell 636.0% year-over-year to 61.18%; the TTM figure through Mar 2026 stood at 74.11% (down 42.0% YoY), while the FY2025 annual figure was 75.05%, down 28.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 61.18%, down from 79.27% in the prior quarter.
  • The five-year high for Gross Margin was 79.27% in Q4 2025, with the low at 61.18% in Q1 2026.
  • The 5-year median for Gross Margin is 70.62% (2023), against an average of 71.73%.
  • The sharpest annual moves came in 2024 and 2026: Gross Margin surged 994 bps in 2024, then plunged 636 bps in 2026.
  • Harrow's Gross Margin stood at 69.67% in 2022, then fell by 1 bps to 68.91% in 2023, then climbed by 14 bps to 78.85% in 2024, then increased by 1 bps to 79.27% in 2025, then declined by 23 bps to 61.18% in 2026.
  • Business Quant data shows HROW's Gross Margin at 61.18% in Q1 2026, 79.27% in Q4 2025, and 75.28% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn 51.98%
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn 87.30%
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Harrow 1.55 Bn 1.46 Bn 50.36 Mn 71.27%

Historic Data

Download Data
DateValue
Jun 30, 2026 71.27%
Mar 31, 2026 61.18%
Dec 31, 2025 79.27%
Sep 30, 2025 75.28%
Jun 30, 2025 74.54%
Mar 31, 2025 67.54%
Dec 31, 2024 78.85%
Sep 30, 2024 75.60%
Jun 30, 2024 74.38%
Mar 31, 2024 69.49%
Dec 31, 2023 68.91%
Sep 30, 2023 70.62%
Jun 30, 2023 70.12%
Mar 31, 2023 68.31%
Dec 31, 2022 69.67%
Sep 30, 2022 70.55%
Jun 30, 2022 71.98%
Mar 31, 2022 73.04%
Dec 31, 2021 74.84%
Sep 30, 2021 73.56%